<DOC>
	<DOCNO>NCT02523898</DOCNO>
	<brief_summary>Polycystic ovary syndrome ( PCOS ) common cause anovulatory infertility affect 12-21 % population.Several study perform evaluate possible benefit metformin alone combination clomiphene ( CC ) first-line treatment infertility woman PCOS report conflict result . These conflict result may due presence absence insulin resistance ( IR ) .Metformin decrease IR .However single randomize clinical trial metformin IR PCOS patient . Therefore , aim current study compare CC coadministration metformin CC coadministration placebo IR PCOS patient induce ovulation .</brief_summary>
	<brief_title>Metformine CC Compared With Placebo CC Induction Ovulation PCOS Patients With Insulin Resistant</brief_title>
	<detailed_description>Introduction : PCOS common cause anovulatory infertility affect 12-21 % population . This percentage may vary accord criterion use population studied.Hyperandrogenism , chronic anovulation , occasionally obesity characteristic syndrome . Currently , CC first-line infertility treatment woman PCOS .However , 20-25 % PCOS woman fail ovulate incremental dos CC respond due resistance CC .IR hyperinsulinemia consider important factor pathogenesis PCOS .Hence , lean obese woman PCOS may IR.Hyperinsulinism show play part ovarian hyperandrogenism may directly influence even prevent ovulation.Metformin , insulin sensitize agent , reduces level luteinizing hormone , hyperinsulinemia also decrease ovarian production androgen .For reason number study perform evaluated possible beneficial role metformin manage woman PCOS . However , study perform evaluate possible benefit metformin alone combination CC first-line treatment infertility woman PCOS report conflict result .Recently meta-analysis concluded metformin burdensome placebo , hence CC alone CC plus metformin drug choice patients.A high-quality Cochrane systematic review report randomized control trial ( RCTs ) compare metformin CC woman PCOS demonstrate CC significantly high pregnancy live birth rate woman BMI &gt; 30 kg/m2 whereas metformin good result woman BMI &lt; 30 kg/m2.Lately , meta-analysis report due conflicting finding heterogeneity across included RCTs , insufficient evidence establish difference metformin CC term ovulation , pregnancy , live birth , miscarriage multiple pregnancy rate nonobese woman PCOS . It propose caution proceed prescribe metformin first line pharmacological therapy group woman rigorous trial do . These conflict result publish study may due large difference heterogeneity study population , particularly possible presence absence IR . Metformin decrease IR , however single RCTwith metformin IR PCOS patient . Therefore , aim current study compare CC coadministration metformin CC coadministration placebo IR PCOS patient induce ovulation . Methods material : A total 388 IR woman PCOS enrol study infertility clinic Amir-Al-Momenin Hospital , Semnan , Iran november 2015 april 2020 . All patient inform study possible complication drug consultant inform consent sign . This study supervise approve Research Council Ethical Committee Semnan University Medical Sciences . For randomization random block allocation method use , six block four component present : AABB , BBAA , ABAB , BABA , ABBA , BAAB . A random digit number table generator select sort block apply . The allocation sequence conceal sequentially number , seal envelope . This process prepare statistician Clinical Epidemiology Unit Research Center . The corresponding envelope open nurse blind study , patient enrol . Sample size : By take result study Moll et al account , show metformin plus CC result 39.5 % pregnancy rate compare 27.1 % pregnancy rate CC ; assume result investigator ' propose study , do IR woman , consistent result obtain study , sample size calculate 388 use follow formula , compare two proportion , supposes maximum error type 1 2 5 % 20 % respectively , provide two group equal trial one side . Estimated sample size two-sample comparison proportion Test Ho : p1 = p2 , p1 proportion population 1 p2 proportion population 2 Assumptions : alpha = 0.0500 ( one-sided ) power = 0.8000 p1 = 0.3950 p2 = 0.2710 d=p1-p2=0.1240 n2/n1 = 1.00 Estimated required sample size : n1 = 194 n2 = 194 Women randomly allocate CC ( 100mg daily begin cycle day 3 5 day spontaneous menses withdrawal bleed induce progestin administration ( medroxyprogesterone acetate [ Provera ] , 5 mg per day for10 day 3 menstrual cycles.There least 5 day pill free interval progesterone ( P ) clomid . The dose increase subsequent cycle case nonresponse ( follicle &lt; 12mm day 16 CC cycle . ) The maximum daily dose clomiphene 150 mg ( three pill ) , give 5 day plus metformin ( 1500mgdaily start ) ( group A ; n=194 ; ) CC plus placebo ( group B ; n=194 ) . Study Design : All woman examine clinically weight , height , body mass index ( BMI ) , pulse blood pressure record . These measurement take nurse unaware admission number patient . BMI calculate weight divide height square ( kg/m2 ) . After overnight fast 10 12 h , blood sample obtain determination fast blood glucose ( FBG ) , insulin , FSH , LH , estradiol ( E2 ) , total free testosterone ( T ) , DHEAS , PRL , TSH , 17OH progesterone exclusion 21-hydroxylasedeficient nonclassic adrenal hyperplasia ( NCAH ) 3rd day spontaneous menses withdrawal bleed induce Provera . All blood sample centrifuge store -20°C assay together . Serum level FSH , LH , TSH PRL measure use Enzyme-linked immunosorbent assay ( ELISA , Wernecce,3200 ) ( Ideal , Tehran , Iran ) . Total T , FreeT , DHEAS insulin also measure use ELISA assay ( Monobind , Inc , USA ) . FBG measure use enzymatic colorimetric method Glucose Oxidase . IR determine homeostatic model assessment ( HOMA ) method calculate fasting insulin ( mU/L ) × fast glucose ( mmol/L ) / 22.5 . The value HOMA-IR ≥2.3 assume IR accord Hosseinpanah et al studies´ iranian woman .After baseline study complete , patient divide two group . In group1 metformin ( Metformine , Chemidaro , Tehran , Iran ) give dose 500 mg three time day 8weeks . The dose increase one three tablet day period seven day minimize side effect . The patient group two receive placebo ( identical appearance metformin factory ) . The P level subject measure every week order document ovulation . A P level &gt; 5 ng/ml ( 16 nmol per liter ) consider confirmatory ovulation . If pregnancy occur , metformin continue another 12 week . In case failure ovulation end period , metformin placebo continue patient give 100 mg CC ( Clomid , Iran Hormone , Iran ) 5 day start day 3 spontaneous menses withdrawal bleed induced Provera.Ovarian follicular response monitor transvaginal sonography every day day 10 cycle single sonographist . When least one follicle reach ≥18 mm diameter , 5000 IU HCG ( Pregnyl ; N.V. Organon , OSS , Netherlands ) give intramuscularly timed intercourse advise ( every day one week start receive HCG ) . If follicle ≥12mm day 16 CC cycle , cycle presume anovulatory monitoring discontinue . In case ovulation CC without pregnancy , patient advise participate two similar cycle therapy 100 mg CC ( group1 2 ) . When ovulation occur 100 mg CC , dose increase 150 mg treatment protocol use dose . In group 1 metformine group 2 placebo continue CC cycle . Clinical pregnancy define detection least one gestational sac transvaginal ultrasound examination start one week miss period.Ongoing pregnancy define detection fetal heart activity 12 week gestation . Statistical analysis : All data enter SPSS software ( Version 11.5.0 , © SPSS Inc. ) , T-test ( Mann-Whitney test need ) , ANOVA quantitative variable , Chi-square test Fisher exact test necessary qualitative variable use . P &lt; 0.05 consider significant test .</detailed_description>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Hyperandrogenism</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<mesh_term>Progestins</mesh_term>
	<criteria>Insulin resistant ( HOMAIR≥2.3 ) PCOS woman 2036 year age , period infertility 1 year normal serum prolactin T4and TSH , normal hystero salpingography infertility factor . The diagnosis PCOS accord Rotterdam Criteria . Diabetic woman Any medication could influence carbohydrate metabolism pituitarygonadal function least 2 month study Hypertension abnormal renal liver function test Ovarian drilling .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>36 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Clomiphene</keyword>
	<keyword>infertility</keyword>
	<keyword>insuline resistant</keyword>
	<keyword>metformine</keyword>
	<keyword>PCOS</keyword>
</DOC>